Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure
Stopped Very slow recruitment of patients and the current COVID-19 pandemic situation.
Conditions
- Acute-On-Chronic Liver Failure
Interventions
- BIOLOGICAL: allo-APZ2-ACLF
Sponsor
RHEACELL GmbH & Co. KG
Collaborators
- [object Object]
- [object Object]